Study guide

12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain

Australian Dental Council ADC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Examination Overview

1.1 ADC Written Examination Structure, Scoring Clusters & Australian Practice Context 1.2 Clinical Scenario Reasoning & Australian Therapeutic Guidelines Alignment

2 Chapter 2: Restorative Dentistry & Fixed Prosthodontics

2.1 Minimal Intervention Dentistry, Caries Risk & Lesion Management 2.2 Direct Restorative Materials, Resin Composites & Dental Amalgam 2.3 Indirect Restorations, Crown Preparation, Veneers & Onlays 2.4 Dental Adhesion, Etch-and-Rinse vs Self-Etch Systems & Hybrid Layer 2.5 Diagnosis & Management of Tooth Wear (Erosion, Attrition, Abrasion, Abfraction)

3 Chapter 3: Dental Pharmacology & Therapeutic Guidelines

3.1 Local Anaesthetic Agents, Vasoconstrictors & Injection Techniques 3.2 Dental Analgesia Protocols, NSAIDs, Paracetamol & Opioid Stewardship 3.3 Dental Antibiotic Prescribing, Prophylaxis & Therapeutic Guidelines 3.4 Management of Patients on Anticoagulants & Antiplatelet Therapy 3.5 Medication-Related Osteonecrosis of the Jaw (MRONJ) Risk & Management

4 Chapter 4: General Medicine & Medically Compromised Patients

4.1 Dental Office Medical Emergencies, Anaphylaxis & Resuscitation Protocols 4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases 4.3 Special Needs Dentistry, Geriatric Care & Dental Management in Pregnancy 4.4 Infective Endocarditis Prophylaxis & Cardiac Risk Assessment

5 Chapter 5: Oral Medicine & Oral Pathology

5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases 5.2 Oral Potentially Malignant Disorders (OPMDs) & Oral Cancer Screening 5.3 Salivary Gland Disorders, Sialadenitis & Cysts of the Jaws 5.4 Oral Biopsy Indications, Diagnostic Pathways & Specialist Referral

6 Chapter 6: Endodontics

6.1 Pulpal and Periapical Diagnostic Classification & Diagnostic Testing 6.2 Canal Instrumentation, Working Length & Irrigation Protocols 6.3 Root Canal Obturation, Endodontic Retreatment & Failure Analysis 6.4 Endodontic Management of Traumatic Dental Injuries & Vital Pulp Therapy

7 Chapter 7: Oral Surgery

7.1 Surgical & Simple Exodontia Techniques & Intraoperative Complications 7.2 Assessment & Surgical Management of Impacted Third Molars 7.3 Oroantral Communication, Displacement & Trigeminal Nerve Injury Prevention 7.4 Management of Spreading Odontogenic Infections & Fascial Space Abscesses

8 Chapter 8: Paediatric Dentistry & Orthodontics

8.1 Primary Tooth Pulpotomy, Pulpectomy & Stainless Steel Crown Restoration 8.2 Early Childhood Caries, Space Maintenance & Traumatic Primary Dentition 8.3 Malocclusion Classification, Etiology & Interceptive Orthodontic Management 8.4 Non-Pharmacological Behaviour Guidance, Child Protection & Consent

9 Chapter 9: Periodontics

9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment 9.2 Subgingival Debridement, Plaque Control & Antimicrobial Adjuncts 9.3 Periodontal Surgical Flaps, Regenerative Therapy & Furcation Management 9.4 Supportive Periodontal Care, Maintenance Protocols & Risk Re-evaluation

10 Chapter 10: Preventive Dentistry

10.1 Caries Risk Assessment Models (CAMBRA) & Personalised Prevention 10.2 Fluoride Mechanisms, Topical Applications & Community Fluoridation 10.3 Dietary Counselling, Stephan Curve Dynamics & Erosion Prevention 10.4 Pit and Fissure Sealants, Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)

11 Chapter 11: Dental Emergencies

11.1 Emergency Management of Severe Odontogenic Pain & Acute Irreversible Pulpitis 11.2 Acute Management of Avulsed, Luxated & Fractured Permanent Teeth 11.3 Diagnosis, Differentiation & Treatment of Cracked Tooth Syndrome 11.4 Emergency Management of Post-Extraction Hemorrhage & Acute Abscesses

12 Chapter 12: Pain & Behaviour Management

12.1 Assessment & Management of Dental Anxiety, Phobia & Dental Fear 12.2 Nitrous Oxide Inhalation Sedation & Intravenous Sedation Guidelines 12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain 12.4 Informed Consent, Patient Autonomy, Ethics & Professional Boundaries

13 Chapter 13: Removable Prosthodontics

13.1 Complete Denture Design, Impression Techniques & Maxillomandibular Relations 13.2 Removable Partial Denture Design, Surveying, Clasping & RPI System 13.3 Post-Insertion Problems, Sore Spots, Relining & Rebase Procedures 13.4 Denture Stomatitis, Tissue Conditioning & Pre-Prosthetic Surgery

14 Chapter 14: Dental Radiography & Imaging

14.1 Radiation Physics, ALARA Principles, Shielding & Dose Reduction 14.2 Intraoral Radiographic Techniques, Positioning & Geometry 14.3 Radiographic Interpretation, Normal Anatomical Landmarks & Artifacts

15 Chapter 15: Infection Prevention & Control

15.1 Standard & Transmission-Based Precautions in Dental Practice 15.2 Instrument Reprocessing, Autoclaving & Sterilisation Monitoring 15.3 Dental Unit Waterlines, Waste Management & Occupational Exposure Protocols

16 Chapter 16: Dental Implants & Peri-Implant Diseases

16.1 Patient Selection, Bone Density, Anatomic Constraints & Prosthetic Planning 16.2 Peri-Implant Anatomy, Hygiene Protocols & Maintenance Monitoring 16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases

12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain

Key Takeaways Explain This Topic AI

The Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) categorises conditions into Axis I (physical diagnoses such as myofascial pain and joint disc displacements) and Axis II (psychosocial impact and pain-related disability).

Disc displacement with reduction is characterized by reciprocal clicking during jaw movement with normal range of motion, whereas acute disc displacement without reduction presents with sudden restricted mouth opening (closed lock) and absence of joint clicks.

Conservative, non-invasive management represents the primary treatment standard for TMDs, encompassing patient education, soft diet, thermal therapy, physical therapy, short-term NSAIDs, and full-coverage hard acrylic stabilization splints.

Irreversible occlusal adjustment or equilibration is strictly non-evidence-based and contraindicated as a primary treatment for temporomandibular disorders.

Trigeminal neuralgia presents as severe, paroxysmal, electric shock-like facial pain triggered by light tactile stimuli along V2/V3 distributions, managed pharmacologically with Carbamazepine as first-line therapy.

Last updated: August 2026

12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain

Temporomandibular Disorders (TMD) comprise a heterogeneous group of musculoskeletal and neuromuscular conditions involving the temporomandibular joints (TMJs), masticatory muscles, and associated anatomical structures. TMD is the primary cause of non-dental orofacial pain in dental practice, predominantly affecting individuals aged 20 to 40 years with a female-to-male ratio of approximately 4:1. For the ADC Written Examination , candidates must master the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) , differentiate intra-articular disc derangements from extra-articular myofascial pain, execute conservative evidence-based therapy, and accurately diagnose neuropathic facial pain conditions such as trigeminal neuralgia.

1. Diagnostic Framework: The DC/TMD Standard

The international DC/TMD protocol employs a dual-axis diagnostic framework for comprehensive assessment:

Axis I (Physical Diagnoses): Validated clinical decision trees and physical examination protocols categorizing TMD into:

Masticatory Muscle Disorders: Myalgia (local muscle soreness), Myofascial Pain (pain spreading beyond palpated muscle site), and Myofascial Pain with Referral (pain referring to distant sites such as teeth, ear, or temple).

Temporomandibular Joint Disorders: Disc displacement with reduction, Disc displacement with reduction with intermittent locking, Disc displacement without reduction with limited opening (acute closed lock), Disc displacement without reduction without limited opening (chronic closed lock), Arthralgia, and Degenerative Joint Disease (Osteoarthritis / Osteoarthrosis).

Axis II (Psychosocial Assessment): Standardized questionnaires evaluating pain intensity, pain-related disability (Graded Chronic Pain Scale), psychological distress (depression, anxiety, somatisation), and jaw functional limitation.

2. Standardized Physical Examination Protocol

Clinical examination requires precise, calibrated physical techniques:

Muscle & Joint Palpation Pressure:

Masticatory muscles (masseter, temporalis body/tendon, medial pterygoid): Palpated with a standardized pressure of 1.0 kg (9.8 N) for 5 seconds.

TMJ lateral pole and posterior attachment: Palpated with 0.5 kg (4.9 N) pressure in both static and dynamic jaw positions.

Range of Motion Measurements (using millimeter ruler):

Unassisted Maximum Opening (MOU): Normal is ≥ 40 mm (including vertical interincisal overlap/overbite).

Assisted Maximum Opening (Passive Stretch / End-Feel): Evaluates soft-tissue vs bony restriction.

Lateral Excursions & Protrusion: Normal lateral excursion is ≥ 7 mm symmetrically to left and right; normal protrusion is ≥ 7 mm .

Joint Sounds Auscultation & Palpation:

Clicking: Single, brief, high-pitched joint sound occurring during opening, closing, or lateral movements.

Crepitus: Rough, continuous, gravel-like grating sound indicative of articular cartilage degradation and osseous surface erosion (Osteoarthritis).

3. Differential Diagnosis of TMJ Internal Derangements

Correctly identifying articular disc derangements dictates clinical prognosis and management:

Diagnostic Entity Clinical Presentation Joint Sounds Mouth Opening & Range of Motion Deflection / Deviation

Disc Displacement with Reduction Disc displaced anteriorly at rest; reduces (pops back on head of condyle) during opening Reciprocal clicking (click on opening and click just before complete closure) Normal range of motion (MOU ≥ 40 mm) Transient S-shaped deviation toward affected side during opening, returning to midline

Acute Disc Displacement without Reduction (Closed Lock) Disc remains anteriorly displaced throughout movement; fails to reduce Absence of joint clicks (history of clicking that suddenly ceased) Severe limitation of opening (MOU typically 20–25 mm); hard painful end-feel Uncorrected deflection to the affected side at maximum opening

Chronic Disc Displacement without Reduction Long-standing displaced disc; retrodiscal tissue adapts into pseudo-disc Joint sounds minimal or absent Opening gradually improves (MOU 35–40 mm) due to tissue stretch; minimal pain Slight residual deflection to affected side

Osteoarthritis (Degenerative Joint Disease) Organic cartilage breakdown and subchondral bone remodeling Coarse crepitus on palpation and movement Variable restriction; joint stiffness in morning Variable deflection

4. Evidence-Based Conservative Management Ladder for TMD

National guidelines (including the Australian Dental Association and international TMD consensus bodies) emphasize that over 85% of TMD cases resolve or significantly improve with non-invasive conservative therapy . Invasive, irreversible treatments should be avoided.

Step 1: Self-Management & Behavioural Education

Patient reassurance regarding the benign, self-limiting nature of most TMDs.

Dietary Modification: Soft food diet; avoiding hard, chewy foods, chewing gum, and large bites.

Jaw Rest & Habits Correction: Discouraging daytime clenching, lip/cheek biting, and fingernail biting. Adopting the relaxed jaw posture: "Lips together, teeth apart, tongue resting softly behind upper front teeth."

Thermal Therapy: Applying moist warm heat packs to masticatory muscles for 15–20 minutes 2–3 times daily for muscle spasm, or cold ice packs for acute joint inflammation.

Physiotherapy & Exercises: Gentle passive stretching, Rocabado 6x6 stabilization exercises, and trigger point massage.

Step 2: Pharmacotherapy

Short-Term NSAIDs: First-line for acute arthralgia and myalgia (e.g., Ibuprofen 400 mg qid or Naproxen 250–500 mg bd taken with food for 10–14 days continuously, not as-needed).

Muscle Relaxants: Short-term nocturnal low-dose benzodiazepines (e.g., Diazepam 2–5 mg nocte for 5–7 days max) for acute muscle spasm.

Tricyclic Antidepressants (TCAs): Low-dose Amitriptyline (10–25 mg nocte) for chronic myofascial pain and sleep fragmentation.

Step 3: Occlusal Appliance Therapy (Splint Therapy)

Stabilization Splint (Michigan / Tanner Splint): Full-coverage, hard clear acrylic appliance fitted to the maxillary or mandibular arch. Provides flat, even centric contact points for all opposing teeth and canine guidance during lateral excursions.

Mechanism: Reduces joint load, distributes parasomnia clenching forces, redistributes sensory input, and protects teeth from attrition.

Clinical Rule: Soft splints are generally avoiding in bruxism as they may increase nocturnal clenching activity.

Anterior Positioning Splint: Holds the mandible in a protruded position to keep the disc reduced; used short-term (nighttime only for 4–6 weeks) for symptomatic disc displacement with reduction to relieve acute joint pain. Extended use carries high risk of irreversible posterior open bite.

CRITICAL ADC EXAM RULE: Irreversible occlusal adjustment, full-mouth equilibration, orthodontics, or prosthodontic reconstruction are contraindicated as primary treatments for TMD. Multiple systematic reviews confirm no causal link between occlusal interference and TMD onset.

5. Chronic Neuropathic & Non-Odontogenic Orofacial Pain

Clinicians must differentiate musculoskeletal TMD from neuropathic or vascular facial pain to prevent inappropriate dental interventions (e.g., root canal treatment or extractions for non-odontogenic pain).

A. Trigeminal Neuralgia (Tic Douloureux)

Clinical Features: Unilateral, excruciating, paroxysmal, lancinating, electric shock-like or stabbing pain limited to one or more branches of the trigeminal nerve (most commonly V2 or V3 ). Attacks last from a few seconds to 2 minutes, followed by a refractory period.

Triggers: Evoked by trivial non-painful tactile stimuli to trigger zones (e.g., light touch to cheek, washing face, shaving, brushing teeth, talking, cold wind).

Etiology: Microvascular compression of the trigeminal nerve root entry zone by an aberrant arterial loop (most commonly the superior cerebellar artery).

First-Line Pharmacotherapy: Carbamazepine (100–200 mg bd initial dose, titrated up to 400–1200 mg daily). Mandatory Pre-requisite: Baseline Full Blood Count (FBC) and Liver Function Tests (LFTs) due to risks of aplastic anaemia, agranulocytosis, and hepatotoxicity.

B. Burning Mouth Syndrome (BMS / Glossodynia)

Clinical Features: Chronic, intraoral burning, tingling, or dysaesthesia occurring daily for >3 months, without visible mucosal lesions or underlying medical conditions. Most commonly affects the anterior two-thirds of the tongue, hard palate, and lower lip in postmenopausal females.

Diagnostic Protocol: BMS is a diagnosis of exclusion. Clinicians must systematically rule out:

Local causes: Oral candidiasis, geographic tongue, oral lichen planus, hyposalivation/xerostomia.

Systemic causes: Iron deficiency anaemia, Vitamin B12 / Folate deficiency, Type 2 diabetes mellitus, thyroid dysfunction.

Medication side effects: ACE inhibitors (e.g., Captopril, Enalapril), antiretrovirals.

Management: Explanation, reassurance, low-dose systemic clonazepam, alpha-lipoic acid, or topical clonazepam mouth rinses.

Loading diagram... DC/TMD Axis I Diagnostic Decision Tree for Jaw Pain and Restricted Opening